Selected research
Industry Research
Fourth Generation Fluoroquinolones Industry Research Report 2026
Market perspective
The global Fourth Generation Fluoroquinolones market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fourth Generation Fluoroquinolones is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fourth Generation Fluoroquinolones is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fourth Generation Fluoroquinolones include Takeda, Sanofi, Nanjing Youke Pharmaceutical, Pfizer, Daiichi Sankyo Co., Ltd., Otsuka Holdings, Bayer AG and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fourth Generation Fluoroquinolones market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fourth Generation Fluoroquinolones Market by Company
Takeda
Sanofi
Nanjing Youke Pharmaceutical
Pfizer
Daiichi Sankyo Co., Ltd.
Otsuka Holdings
Bayer AG
Astellas
Fourth Generation Fluoroquinolones Segment by Type
Besifloxacin
Delafloxacin
Jimmyfloxacin
Gatifloxacin
Moxifloxacin
Prulifloxacin
Sitafloxacin
Others
Fourth Generation Fluoroquinolones Segment by Application
Skin And Soft Tissue Infections
Urinary Tract Disease
Respiratory Diseases
Bone, Joint, And Soft Tissue Infections
Intestinal Infections And Typhoid Fever
Others
Fourth Generation Fluoroquinolones Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fourth Generation Fluoroquinolones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fourth Generation Fluoroquinolones and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fourth Generation Fluoroquinolones.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fourth Generation Fluoroquinolones manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fourth Generation Fluoroquinolones by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fourth Generation Fluoroquinolones in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Besifloxacin
- Delafloxacin
- Jimmyfloxacin
- Gatifloxacin
- Moxifloxacin
- Prulifloxacin
- Sitafloxacin
- Others
Applications
- Skin And Soft Tissue Infections
- Urinary Tract Disease
- Respiratory Diseases
- Bone, Joint, And Soft Tissue Infections
- Intestinal Infections And Typhoid Fever
- Others
Companies covered
- Takeda
- Sanofi
- Nanjing Youke Pharmaceutical
- Pfizer
- Daiichi Sankyo Co., Ltd.
- Otsuka Holdings
- Bayer AG
- Astellas
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fourth Generation Fluoroquinolones Market Size (2021-2032)
- 2.2.2 Global Fourth Generation Fluoroquinolones Sales (2021-2032)
- 2.2.3 Global Fourth Generation Fluoroquinolones Market Average Price (2021-2032)
- 2.3 Fourth Generation Fluoroquinolones by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Besifloxacin
- 2.3.3 Delafloxacin
- 2.3.4 Jimmyfloxacin
- 2.3.5 Gatifloxacin
- 2.3.6 Moxifloxacin
- 2.3.7 Prulifloxacin
- 2.3.8 Sitafloxacin
- 2.3.9 Others
- 2.4 Fourth Generation Fluoroquinolones by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Skin And Soft Tissue Infections
- 2.4.3 Urinary Tract Disease
- 2.4.4 Respiratory Diseases
- 2.4.5 Bone, Joint, And Soft Tissue Infections
- 2.4.6 Intestinal Infections And Typhoid Fever
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fourth Generation Fluoroquinolones Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fourth Generation Fluoroquinolones Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Fourth Generation Fluoroquinolones Revenue of Manufacturers (2021-2026)
- 3.4 Global Fourth Generation Fluoroquinolones Average Price by Manufacturers (2021-2026)
- 3.5 Global Fourth Generation Fluoroquinolones Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fourth Generation Fluoroquinolones, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fourth Generation Fluoroquinolones, Product Type & Application
- 3.8 Global Manufacturers of Fourth Generation Fluoroquinolones, Established Date
- 3.9 Global Fourth Generation Fluoroquinolones Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Fourth Generation Fluoroquinolones Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Fourth Generation Fluoroquinolones Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Nanjing Youke Pharmaceutical
- 4.3.1 Nanjing Youke Pharmaceutical Company Information
- 4.3.2 Nanjing Youke Pharmaceutical Business Overview
- 4.3.3 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Product Portfolio
- 4.3.5 Nanjing Youke Pharmaceutical Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Fourth Generation Fluoroquinolones Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Daiichi Sankyo Co., Ltd.
- 4.5.1 Daiichi Sankyo Co., Ltd. Company Information
- 4.5.2 Daiichi Sankyo Co., Ltd. Business Overview
- 4.5.3 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Product Portfolio
- 4.5.5 Daiichi Sankyo Co., Ltd. Recent Developments
- 4.6 Otsuka Holdings
- 4.6.1 Otsuka Holdings Company Information
- 4.6.2 Otsuka Holdings Business Overview
- 4.6.3 Otsuka Holdings Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Otsuka Holdings Fourth Generation Fluoroquinolones Product Portfolio
- 4.6.5 Otsuka Holdings Recent Developments
- 4.7 Bayer AG
- 4.7.1 Bayer AG Company Information
- 4.7.2 Bayer AG Business Overview
- 4.7.3 Bayer AG Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer AG Fourth Generation Fluoroquinolones Product Portfolio
- 4.7.5 Bayer AG Recent Developments
- 4.8 Astellas
- 4.8.1 Astellas Company Information
- 4.8.2 Astellas Business Overview
- 4.8.3 Astellas Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Astellas Fourth Generation Fluoroquinolones Product Portfolio
- 4.8.5 Astellas Recent Developments
5 Global Fourth Generation Fluoroquinolones Market Scenario by Region
- 5.1 Global Fourth Generation Fluoroquinolones Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fourth Generation Fluoroquinolones Sales by Region: 2021-2032
- 5.2.1 Global Fourth Generation Fluoroquinolones Sales by Region: 2021-2026
- 5.2.2 Global Fourth Generation Fluoroquinolones Sales by Region: 2027-2032
- 5.3 Global Fourth Generation Fluoroquinolones Revenue by Region: 2021-2032
- 5.3.1 Global Fourth Generation Fluoroquinolones Revenue by Region: 2021-2026
- 5.3.2 Global Fourth Generation Fluoroquinolones Revenue by Region: 2027-2032
- 5.4 North America Fourth Generation Fluoroquinolones Market Facts & Figures by Country
- 5.4.1 North America Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
- 5.4.3 North America Fourth Generation Fluoroquinolones Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fourth Generation Fluoroquinolones Market Facts & Figures by Country
- 5.5.1 Europe Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
- 5.5.3 Europe Fourth Generation Fluoroquinolones Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fourth Generation Fluoroquinolones Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fourth Generation Fluoroquinolones Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fourth Generation Fluoroquinolones Market Facts & Figures by Country
- 5.7.1 South America Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
- 5.7.3 South America Fourth Generation Fluoroquinolones Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Fourth Generation Fluoroquinolones Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fourth Generation Fluoroquinolones Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fourth Generation Fluoroquinolones Sales by Type (2021-2032)
- 6.1.1 Global Fourth Generation Fluoroquinolones Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Fourth Generation Fluoroquinolones Sales Market Share by Type (2021-2032)
- 6.2 Global Fourth Generation Fluoroquinolones Revenue by Type (2021-2032)
- 6.2.1 Global Fourth Generation Fluoroquinolones Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fourth Generation Fluoroquinolones Revenue Market Share by Type (2021-2032)
- 6.3 Global Fourth Generation Fluoroquinolones Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fourth Generation Fluoroquinolones Sales by Application (2021-2032)
- 7.1.1 Global Fourth Generation Fluoroquinolones Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Fourth Generation Fluoroquinolones Sales Market Share by Application (2021-2032)
- 7.2 Global Fourth Generation Fluoroquinolones Revenue by Application (2021-2032)
- 7.2.1 Global Fourth Generation Fluoroquinolones Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fourth Generation Fluoroquinolones Revenue Market Share by Application (2021-2032)
- 7.3 Global Fourth Generation Fluoroquinolones Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fourth Generation Fluoroquinolones Value Chain Analysis
- 8.1.1 Fourth Generation Fluoroquinolones Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fourth Generation Fluoroquinolones Production Mode & Process
- 8.2 Fourth Generation Fluoroquinolones Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fourth Generation Fluoroquinolones Distributors
- 8.2.3 Fourth Generation Fluoroquinolones Customers
9 Global Fourth Generation Fluoroquinolones Analyzing Market Dynamics
- 9.1 Fourth Generation Fluoroquinolones Industry Trends
- 9.2 Fourth Generation Fluoroquinolones Industry Drivers
- 9.3 Fourth Generation Fluoroquinolones Industry Opportunities and Challenges
- 9.4 Fourth Generation Fluoroquinolones Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst